After hours: February 12 at 6:18:06 PM EST Loading Chart for HEPS ...
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results